Crinetics Pharmaceuticals
Crinetics is a San Diego-based pharmaceutical company focused on developing therapies for endocrine diseases and endocrine-related tumors. This role is an Associate Director position within the in vitro pharmacology function, contributing to the company’s drug discovery and development pipeline in endocrinology.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2008
Crinetics Pharmaceuticals, now a Vertex Pharmaceuticals company, is a pharmaceutical company dedicated to discovering, developing, and commercializing treatments for endocrine diseases. Based in San Diego, CA, the company maintains a pipeline of novel therapies including Paltusotine (an oral SST2 agonist) and Atumelnant (an oral ACTH antagonist). Crinetics aims to be the premier endocrine-rooted global pharmaceutical company, focused on improving the lives of patients with endocrine disorders.
Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf.
3 days ago
WINTON GROUP Ltd Takes Position in Crinetics Pharmaceuticals, Inc. $CRNX
1 day ago
Will Crinetics Pharmaceuticals Inc. stock attract more institutional investors - Insider Buying & High Win Rate Trade Alerts
4 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Crinetics Pharmaceuticals.
Why Crinetics Pharmaceuticals (CRNX) Is Down 7.1% After Deeper 2025 Loss And New US$207 Million Shelf Registration
1 week ago
Senior Scientist, In Vitro and In Vivo Pharmacology
Kiniksa Pharmaceuticals
Scientist I/II in In Vitro Pharmacology
Zealand Pharma
Scientist I/II in In Vitro Pharmacology
Zealand Pharma
Principal Scientist - In Vitro Biology & Pharmacology
Zealand Pharma
Director, Molecular Pharmacology
Deep Apple Therapeutics
Senior Principal Scientist, In Vitro Pharmacology
Flagship Pioneering, Inc.